Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following ...
300,000 Venezuelans Lose Protected Immigration Status: Trump Official Says Program Is 'Contrary To The National Interest'
The Trump administration has rescinded Temporary Protected Status (TPS) for more than 300,000 Venezuelans in the United States, leaving them vulnerable to deportation in the coming months.
Robert Kiyosaki Predicts Gold, Silver, Bitcoin Crash Over Trump's Tariffs—Says It's A Buying Moment
Noted investor and author Robert Kiyosaki has forecast a potential Bitcoin (CRYPTO: BTC) crash, which he sees as a chance to amass more wealth< ...
'The Economics Of AI Are About To Change Completely': Why OpenAI's o3 Could Reshape The Industry — Costing Up To $3000 Per Query
OpenAI, valued at $157 billion, may charge up to $2,000 monthly for full access to o3, according to The Economist, which cited New Street Research analyst Pierre Ferragu. Even the company’s current ...